GeneDx Holdings Corp. (WGS) Earnings Call Analysis
NASDAQ · Healthcare · Health Information Services
Earnings Reports
-
GeneDx (WGS) Q1 2026: Exome and Genome Volume Jumps 34% as Guidance Resets on Mix Shift
May 05, 2026
-
GeneDx (WGS) Q4 2025: Exome and Genome Revenue Jumps 54% as Sales Force Expansion Targets Untapped Markets
February 24, 2026
-
GeneDx (WGS) Q3 2025: Exome and Genome Volume Up 33%, Fueling Data Flywheel and Margin Expansion
October 28, 2025
-
GeneDx (WGS) Q2 2025: Exome and Genome Revenue Jumps 69% as Pediatric Expansion Accelerates
July 29, 2025
-
GeneDx (WGS) Q1 2025: Exome and Genome Revenue Climbs 62% as NICU, AI, and Fabric Genomics Expand Growth Runway
July 04, 2025